Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2020[...]
Marker Therapeutics Announces Dosing of First Patient in Phase 2 Trial[...]
Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results[...]
02/18/2021 | Press release | Distributed by Public on 02/18/2021 15:44
Please select the service you want to use:
Smartlinks | vTv Therapeutics Inc. | News | Crime | Corporate Crime | Health | Local News | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Business Announcement | Biotechnology and Medical Research Companies | Börse Frankfurt | Börse Berlin | Börse München | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago
Back
Copyright ©2006-2021 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact